RabMab

Recombinant monoclonal antibodies are primary antibodies manufactured via cloning antibody-coding genes into high-yield expression vectors, subsequently introduced into expression hosts. This overcomes the limitations of other antibody manufacturing methods, such as genetic drift (in hybridoma production), which can lead to lot-to-lot variation. Abcam’s RabMAb® recombinant technology combines the antigen recognition of the rabbit immune system with the specificity of a monoclonal antibody.

Learn why RabMAb® technology:

• Provides higher affinity and specificity compared to traditional antibodies
• Often gives lower background signal compared to traditional antibodies
• Provides diverse epitope recognition
• Is ideal for studying mouse models
• Is ideal for demanding applications like IHC on FFPE tissue